Literature DB >> 24012831

Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.

Nikki A Hawkins1, Vicki B Benard, April Greek, Katherine B Roland, Diane Manninen, Mona Saraiya.   

Abstract

OBJECTIVE: Despite guidelines recommending cervical cancer screening intervals be extended beyond one year, clinical practice has been slow to change. Patient preferences are a potential barrier. In the Centers for Disease Control's Cervical Cancer (Cx3) Study at Federally Qualified Health Centers (FQHCs) across Illinois, we surveyed patients about screening practices, and assessed beliefs regarding lengthening screening intervals.
METHOD: We analyzed data from 984 low income women in the Cx3 Study (2009-2011). Participants completed a survey assessing health history, knowledge about Pap testing, beliefs and intentions about extending screening intervals, and demographics.
RESULTS: The majority reported annual Pap testing (61%), while only 24% reported a 2-3 year screening interval (recommendation at time of survey). Misunderstandings about the Pap test were prevalent, with over half believing it screened for vaginal, yeast, and sexually transmitted infections (58%-72%). Unfavorable beliefs about extending screening intervals were common. The majority (57%) indicated that they would not wait 3 years to be screened if their physician recommended it, and intentions were associated with knowledge about Pap testing.
CONCLUSION: Most women reported annual cervical cancer screening, and intended to resist longer screening intervals. Patients' lack of knowledge and unfavorable beliefs may serve as barriers to extending screening intervals.
© 2013.

Entities:  

Keywords:  Cervical cancer screening; Early detection of cancer; Healthcare disparities; Patient acceptance of health care; Patient compliance

Mesh:

Year:  2013        PMID: 24012831      PMCID: PMC4374644          DOI: 10.1016/j.ypmed.2013.08.021

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  17 in total

1.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

2.  Screening for cervical cancer: will women accept less?

Authors:  Brenda E Sirovich; Steven Woloshin; Lisa M Schwartz
Journal:  Am J Med       Date:  2005-02       Impact factor: 4.965

3.  Why the Pap test? Awareness and use of the Pap test among women in the United States.

Authors:  Nikki A Hawkins; Crystale Purvis Cooper; Mona Saraiya; Cynthia A Gelb; Lindsey Polonec
Journal:  J Womens Health (Larchmt)       Date:  2011-03-28       Impact factor: 2.681

4.  Predictors of patient comfort and adherence with less frequent cervical cancer screening.

Authors:  Kathy L MacLaughlin; Kurt B Angstman; Priscilla M Flynn; Jessica R Schmitt; Amy L Weaver; Lynne T Shuster
Journal:  Qual Prim Care       Date:  2011

5.  Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?

Authors:  Mona Saraiya; Zahava Berkowitz; K Robin Yabroff; Louise Wideroff; Sarah Kobrin; Vicki Benard
Journal:  Arch Intern Med       Date:  2010-06-14

6.  Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.

Authors:  Helen I Meissner; Jasmin A Tiro; K Robin Yabroff; David A Haggstrom; Steven S Coughlin
Journal:  Med Care       Date:  2010-03       Impact factor: 2.983

7.  Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.

Authors:  Katherine B Roland; Ashwini Soman; Vicki B Benard; Mona Saraiya
Journal:  Am J Obstet Gynecol       Date:  2011-06-12       Impact factor: 8.661

8.  Cancer screening practices among physicians in the national breast and cervical cancer early detection program.

Authors:  Vicki B Benard; Mona S Saraiya; Ashwini Soman; Katherine B Roland; K Robin Yabroff; Jackie Miller
Journal:  J Womens Health (Larchmt)       Date:  2011-07-20       Impact factor: 2.681

9.  Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007.

Authors:  K Robin Yabroff; Mona Saraiya; Helen I Meissner; David A Haggstrom; Louise Wideroff; Gigi Yuan; Zahava Berkowitz; William W Davis; Vicki B Benard; Steven S Coughlin
Journal:  Ann Intern Med       Date:  2009-11-03       Impact factor: 25.391

10.  The frequency of Pap smear screening in the United States.

Authors:  Brenda E Sirovich; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

View more
  17 in total

1.  Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.

Authors:  Vicki B Benard; Mona Saraiya; April Greek; Nikki A Hawkins; Katherine B Roland; Diane Manninen; Donatus U Ekwueme; Jacqueline W Miller; Elizabeth R Unger
Journal:  J Womens Health (Larchmt)       Date:  2013-12-31       Impact factor: 2.681

2.  Cervical cytology screening among low-income, minority adolescents in New York City following the 2009 ACOG guidelines.

Authors:  Jennifer Tsui; Annika M Hofstetter; Karen Soren
Journal:  Prev Med       Date:  2014-03-17       Impact factor: 4.018

3.  Trends in Breast Cancer Screening: Impact of U.S. Preventive Services Task Force Recommendations.

Authors:  Soudabeh Fazeli Dehkordy; Kelli S Hall; Allison L Roach; Edward D Rothman; Vanessa K Dalton; Ruth C Carlos
Journal:  Am J Prev Med       Date:  2015-04-01       Impact factor: 5.043

4.  Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings.

Authors:  H N Pedersen; L W Smith; C Sarai Racey; D Cook; M Krajden; D van Niekerk; G S Ogilvie
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

5.  Acceptable and Preferred Cervical Cancer Screening Intervals Among U.S. Women.

Authors:  Crystale Purvis Cooper; Mona Saraiya; George F Sawaya
Journal:  Am J Prev Med       Date:  2015-07-02       Impact factor: 5.043

6.  Improving Knowledge and Awareness of Human Papillomavirus-Associated Gynecologic Cancers: Results from the National Comprehensive Cancer Control Program/Inside Knowledge Collaboration.

Authors:  Julie S Townsend; Mary Puckett; Cynthia A Gelb; Martin Whiteside; Julia Thorsness; Sherri L Stewart
Journal:  J Womens Health (Larchmt)       Date:  2018-08       Impact factor: 2.681

7.  Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.

Authors:  Mona Saraiya; Vicki B Benard; April A Greek; Martin Steinau; Sonya Patel; L Stewart Massad; George F Sawaya; Elizabeth R Unger
Journal:  Am J Obstet Gynecol       Date:  2014-05-06       Impact factor: 8.661

8.  Racial and ethnic differences in human papillomavirus positivity and risk factors among low-income women in Federally Qualified Health Centers in the United States.

Authors:  Lavinia Lin; Vicki B Benard; April Greek; Nikki A Hawkins; Katherine B Roland; Mona Saraiya
Journal:  Prev Med       Date:  2015-09-09       Impact factor: 4.018

9.  Changes in Knowledge and Beliefs About Human Papillomavirus and Cervical Cancer Screening Intervals in Low-Income Women After an Educational Intervention.

Authors:  Katherine B Roland; Vicki B Benard; April Greek; Nikki A Hawkins; Lavinia Lin
Journal:  J Prim Care Community Health       Date:  2016-01-13

10.  Communication practices about HPV testing among providers in Federally Qualified Health Centers.

Authors:  Lavinia Lin; Vicki B Benard; April Greek; Katherine B Roland; Nikki A Hawkins; Mona Saraiya
Journal:  Prev Med Rep       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.